Hematology TimesCompany withdraws application for eryaspase in ALLNovember 16, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesEMA recommends orphan status for drug in AMLNovember 15, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA grants priority review for midostaurinNovember 15, 2016CythemiasLeukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesCHMP recommends drug for hemophilia ANovember 13, 2016ThrombosisPharmacyRelated Issues
Hematology TimesDrug dubbed ‘breakthrough’ for CTCL subtypesNovember 12, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesHealth Canada approves drug for patients with VTE, NVAFNovember 11, 2016ThrombosisPharmacy
Hematology TimesCHMP recommends expanding use of drug in CLLNovember 11, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA grants drug orphan designation for CTCLOctober 26, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesLegislators question price of leukemia drugOctober 24, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesCHMP recommends conditional approval of drug for CLLOctober 15, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
